Neurotrophins_and_depression
Diuretics and Kidney Function
Thiazides vs. Loop Diuretics:
Thiazides interfere with salt reabsorption at a location further from the kidney papilla, preserving the kidney's ability to concentrate urine.
Unlike loop diuretics, thiazides do not disrupt the 1200 mOsm region around the collecting duct.
Urine Concentration Adjustment:
With thiazides, the kidney still maintains its ability to concentrate urine and produce negative free water.
Urine flow is maintained to balance water, with potential slight upward movement in urine point graph.
Pharmacological Understanding:
Emphasis on the correlation between physiology and drug action to deduce pharmacological effects.
Neurotrophins and Depression
Neurotrophic Factors:
Brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) promote the regrowth and function of serotonergic neurons in adult rats.
BDNF infusion into the dorsal raphe nucleus leads to antidepressant effects.
Environmental Stressors Impacting Depression:
Stress decreases BDNF mRNA, while antidepressants increase BDNF mRNA via specific receptors.
Mechanism of Antidepressants:
Antidepressants block degradation of neurotransmitters (5-HT, noradrenaline) and enhance their synaptic levels by inhibiting their reuptake.
Electroconvulsive therapy (ECT) is reserved for severe cases but also impacts neurotrophin levels after treatment.
Effects of Antidepressants on BDNF
Chronic Antidepressant Treatment:
Leads to elevated BDNF mRNA levels in rat hippocampus.
The increase in BDNF mRNA takes about three weeks, correlating with treatment response delay in humans.
Potential for New Antidepressants:
Drugs targeting neurotrophin production may create a new class of antidepressants, distinct from SSRIs or other monoamine reuptake inhibitors.
Stress, Neurotrophins, and Drug Treatment
Stress-Induced BDNF Decrease:
Prolonged stress lowers BDNF mRNA, but antidepressants can prevent this decrease.
Seizures and BDNF Levels:
Induced seizures elevate BDNF mRNA, similar to effects observed with ECT treatments.
Questions for Future Research:
Investigate the effects of antidepressants on BDNF protein levels and receptor numbers in depressed individuals.
Explore if neurotrophin-boosting agents could provide faster and effective treatment options for resistant depression.
Drug-Resistance Phenomena
Comparison between Tumor Cells and Malarial Parasites:
Drug resistance shares characteristics across tumor cells and malarial parasites (e.g., P. falciparum).
Initial focus on ATP-binding cassette (ABC) proteins and their role in drug resistance.
Role of Ion Exchange Processes:
Recent findings emphasize the potential importance of ion exchange in developing drug resistance rather than solely relying on direct drug transport mechanisms.
Clinical Implications:
Understanding ion exchange processes may offer new therapeutic targets for combating drug resistance in different diseases.